Omega Fund Management LLC

Omega Fund Management LLC latest Q4_2020 13F filings reported $666,876,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is 80.40%. This fund has 19 securities concentrations of 100% weights.

Omega Fund Management LLC largest holding is Replimune Group Inc. with weight of 29.03% and $193,603,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-162020-12-31Q4_202013F-HR19$666,876,00080.40%
2020-11-162020-09-30Q3_202013F-HR16$369,660,0001.07%
2020-08-172020-06-30Q2_202013F-HR15$365,744,00051.37%
2020-05-142020-03-31Q1_202013F-HR16$241,630,000-23.09%
2020-02-132019-12-31Q4_201913F-HR14$314,167,000-3.04%
2019-11-132019-09-30Q3_201913F-HR14$324,015,000-17.36%
2019-08-132019-06-30Q2_201913F-HR15$392,079,00025.71%
2019-05-202019-03-31Q1_201913F-HR/A13$311,888,0000.00%
2019-05-152019-03-31Q1_201913F-HR12$161,207,00019.52%
2019-02-112018-12-31Q4_201813F-HR14$134,874,000-36.20%
2018-11-072018-09-30Q3_201813F-HR14$211,385,00055.98%
2018-08-022018-06-30Q2_201813F-HR13$135,522,00033.19%
2018-05-042018-03-31Q1_201813F-HR12$101,754,000-26.43%
2018-02-052017-12-31Q4_201713F-HR12$138,312,000-21.75%
2017-11-032017-09-30Q3_201713F-HR11$176,759,00010.31%
2017-07-262017-06-30Q2_201713F-HR11$160,239,0004.16%
2017-05-092017-03-31Q1_201713F-HR11$153,841,00024.83%
2017-02-102016-12-31Q4_201613F-HR12$123,236,000-5.92%
2016-11-022016-09-30Q3_201613F-HR11$130,994,000-2.82%
2016-08-032016-06-30Q2_201613F-HR11$134,798,000-6.50%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
REPLIMUNE GROUP INC USD0.001000REPLINCR$193,60358.18%29.03%$38.15-105.05%5,074,783
KRONOS BIO INCKRONBUY$114,0520.00%17.10%$29.870.00%3,818,283
MORPHIC HLDG INCMORFINCR$98,02520.40%14.70%$33.55-101.88%2,921,771
SPRUCE BIOSCIENCES INCSPRBBUY$52,5340.00%7.88%$24.310.00%2,161,022
ATEA PHARMACEUTICALS INCAVIRBUY$35,3960.00%5.31%$41.780.00%847,208
GOSSAMER BIO INCGOSSDECR$32,110-22.08%4.81%$9.670.00%3,320,608
IMMUNIC INCDECR$27,341-17.66%4.10%$15.290.00%1,788,160
CHECKMATE PHARMACEUTICALS INCMPIINCR$19,47826.76%2.92%$14.59-100.00%1,335,050
ARCUTIS BIOTHERAPEUTICS INCARQTDECR$18,009-6.72%2.70%$28.13-102.84%640,199
SYROS PHARMACEUTICALS INCSYRSBUY$16,9530.00%2.54%$10.850.00%1,562,500
PARATEK PHARMACEUTICALS INCPRTKINCR$16,27915.72%2.44%$6.26-100.00%2,600,410
ALPINE IMMUNE SCIENCES INCALPNINCR$16,19043.35%2.43%$12.60-100.00%1,284,900
ESSA PHARMA INCINCR$8,41938.11%1.26%$11.93-122.68%705,693
FIBROGEN INCFGENDECR$4,846-9.79%0.73%$37.090.00%130,646
CIDARA THERAPEUTICS INCCDTXDECR$4,010-29.83%0.60%$2.000.00%2,005,249
TREVI THERAPEUTICS INCTRVIDECR$3,330-39.95%0.50%$2.64-108.18%1,263,408
JOUNCE THERAPEUTICS INCJNCEDECR$2,345-14.20%0.35%$7.000.00%334,965
OBSEVA SAOBSVDECR$2,079-16.10%0.31%$2.080.00%999,364
PIERIS PHARMACEUTICALS INCPIRSINCR$1,87720.79%0.28%$2.50-100.00%750,741
PREVAIL THERAPEUTICS INCPRVLSOLD$00.00%-100.00%$0.000.00%0